Table 3.
Weight loss medications—on and off-label use.
| Young adults | Adolescents | Children | Overall | |
|---|---|---|---|---|
| N = 1,145 | N = 492 | N = 83 | N = 1,720 | |
| ALL PATIENTS | ||||
| Metformin | 484 (42.3) | 280 (56.9) | 41 (49.4) | 805 (46.8) |
| Topiramate | 377 (32.9) | 156 (31.7) | 32 (38.6) | 565 (32.8) |
| Bupropion | 370 (32.3) | 123 (25.0) | 16 (19.3) | 509 (29.6) |
| Phentermine | 141 (12.3) | 47 (9.6) | — | 188 (10.9) |
| Zonisamide | 32 (2.8) | 15 (3.0) | — | 47 (2.7) |
| Naltrexone | 39 (3.4) | — | — | 39 (2.3) |
| Orlistat | 23 (2.0) | — | — | 23 (1.3) |
| Liraglutide | 23 (2.0) | — | — | 23 (1.3) |
| OFF-LABEL USE ONLY | ||||
| N = 644 | N = 299 | N = 46 | N = 989 | |
| Metformin | 255 (39.6) | 173 (57.9) | 24 (52.2) | 452 (45.7) |
| Topiramate | 298 (46.3) | 122 (40.8) | 24 (52.2) | 444 (44.9) |
| Bupropion | 21 (3.3) | 10 (3.3) | — | 31 (3.1) |
| Phentermine | 141 (21.9) | 47 (15.7) | — | 188 (19.0) |
| Zonisamide | 16 (2.5) | — | — | 16 (1.6) |
| Naltrexone | 18 (2.8) | — | — | 18 (1.8) |
| Orlistat | 23 (3.6) | — | — | 23 (2.3) |